Immunotherapy shows promise in cancer treatment
A team of researchers, led by scientists at Yale and the biotech company Genentech, have completed a phase I clinical trial for a new cancer immunotherapy and developed biomarkers to predict its efficacy in patients. The trial’s results look promising for the potential to use personalized medicine and immunotherapies to treat cancer.
Regulate e-cigarettes, researchers say
The American Association for Cancer Research and the American Society of Clinical Oncology released a joint statement on Thursday to discourage the use of electronic cigarettes, citing uncertainty regarding their safety.
Wearing lab coats, medical students “die-in”
Roughly 70 members of the Yale School of Medicine and Yale School of Public Health communities, clad in traditional white lab coats, lay down in front of the medical school for four a half minutes today after assembling at noon.
Segraves departing, but sciences will chug on
An avid backpacker, William Segraves plans to spend time in the wilderness after retiring as associate dean of science education for Yale College, effective this January.
Alpern comes under fire at Med School town hall
Following weeks of controversy surrounding professional and sexual misconduct at the Yale School of Medicine, a Tuesday evening town hall meeting, moderated by School of Medicine Dean Robert Alpern, attracted over 100 faculty members with the promise of addressing their concerns.